Actuate Therapeutics, Inc.
ACTU
$1.32
-$0.05-3.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.87M | -5.63M | -4.55M | -5.41M | -5.95M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.35M | 1.50M | 1.55M | 1.81M | 1.58M |
| Change in Net Operating Assets | -884.30K | -891.50K | -728.80K | -3.08M | 191.30K |
| Cash from Operations | -4.41M | -5.02M | -3.74M | -6.68M | -4.17M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 731.60K | 519.60K | 0.00 | 16.82M | 7.21M |
| Repurchase of Common Stock | 0.00 | -527.70K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -34.60K | -- | -29.30K | 289.50K | -429.50K |
| Cash from Financing | 697.00K | -8.10K | -29.30K | 17.11M | 6.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.71M | -5.03M | -3.77M | 10.43M | 2.60M |